WAY — Waystar Holding Corp.

Waystar Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $320 million, an 18% year-over-year increase.
• Adjusted EBITDA: $137 million, up 21.5% year-over-year, with an adjusted EBITDA margin of 43%.
• Bookings: Strong performance with a notable number of $1 million-plus annual contract value (ACV) bookings.
• Net Revenue Retention (NRR): 108%, consistent with historical ranges.
• Subscription Revenue: $176 million, a 34% increase year-over-year, representing 55% of total revenue.
• Volume-Based Revenue: $142 million, up 3% year-over-year.
• Cash Position: $192 million in cash and equivalents, with $1.5 billion in gross debt.
• Unlevered Free Cash Flow: $64 million, converting 47% of adjusted EBITDA.

2. Strategic Updates and Business Highlights

• Continued momentum with larger provider organizations and expansion across the client base.
• Successful integration of Iodine solutions, contributing to cross-sell opportunities and enhanced client offerings.
• Emphasis on AI-powered solutions, with over 40% of bookings attributed to AI-enabled products.
• Recognition as a top platform in revenue cycle management by KLAS Research.
• Transition in leadership with Steven Oreskovich stepping down as CFO, succeeded by Alpana Wegner.

3. Forward Guidance and Outlook

• Revenue Guidance: Revised range of $1.276 billion to $1.294 billion for the full year, reflecting a 17% year-over-year growth.
• Adjusted EBITDA Guidance: Increased to a range of $535 million to $545 million.
• Expectations for continued strong demand for Waystar’s solutions, particularly in light of evolving healthcare payment dynamics.

4. Challenges and Points of Concern

• Volume-Based Revenue Growth: Slower growth observed, with a noted decline in provider transaction volume.
• Competitive Pressures: Concerns about large health systems potentially leveraging services from EHR vendors, which could impact Waystar's market position.
• Regulatory Environment: Ongoing uncertainty regarding healthcare regulations and the impact on uninsured populations could affect transaction volumes.

5. Notable Q&A Insights

• Market Demand: Clients are increasingly focused on lowering costs and optimizing payment yields, driving demand for Waystar’s comprehensive platform.
• RFP Process: An uptick in RFPs from larger clients, with a trend toward selecting multiple solutions rather than single point solutions.
• Client Decision-Making: Providers prioritize outcomes and ROI over novelty, indicating a preference for proven solutions that enhance revenue cycle management.
• AI Integration: Strong interest in combining clinical and financial intelligence through AI, with early adopters reporting significant revenue recovery from automated solutions.

Overall, Waystar demonstrated robust financial performance in Q2 2026, with strategic initiatives focused on AI integration and client expansion. However, challenges remain in volume-based revenue growth and competitive pressures from EHR vendors. The company maintains a positive outlook with revised guidance and a strong pipeline of opportunities.